mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.06 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.06 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.06 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.06 |